Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.51 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.47 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.44 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.44 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7099138 | 0.91 | KDM4E (0.49) | KDM4EALDH1A1LMNAHTTHPGD | |
| SCHEMBL7100139 | 0.89 | KDM4E (0.48) | KDM4EALDH1A1LMNAHTTHPGD | |
| SCHEMBL6706677 | 0.80 | LMNA (0.47) | KDM4EALDH1A1LMNAHTTHPGD | |
| SCHEMBL6708170 | 0.79 | LMNA (0.46) | KDM4EALDH1A1LMNAHTTHPGD | |
| SCHEMBL6708370 | 0.78 | LMNA (0.45) | KDM4EALDH1A1LMNAHTTHPGD | |
| SCHEMBL7100819 | 0.73 | CSNK2A2 (0.46) | KDM4EALDH1A1NOTUMCSNK2A2CSNK2B | |
| SCHEMBL2854444 | 0.69 | LMNA (0.51) | KDM4EALDH1A1LMNAHTTHPGD | |
| SCHEMBL7098332 | 0.69 | ALDH1A1 (0.50) | KDM4EALDH1A1HTTHPGDMEN1 | |
| SCHEMBL7112238 | 0.66 | LMNA (0.44) | KDM4ELMNAKMT2ATSHR | |
| SCHEMBL7101086 | 0.65 | CSNK2A2 (0.43) | KDM4EALDH1A1LMNANOTUMCSNK2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1347761-A2 | PHARMACEUTICAL FORMULATION CONTAINING THIENOPYRIMIDINES AND ANTITHROMBOTICS, CALCIUM ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES | MERCK PATENT GmbH (DE) | 2003-10-01 | — | — | EP | disclosed |
| EP-1337256-A2 | USE OF THIENOPYRIMIDINES | MERCK PATENT GmbH (DE) | 2003-08-27 | — | — | EP | disclosed |
| WO-2002049650-A2 | PHARMACEUTICAL FORMULATION CONTAINING THIENOPYRIMIDINES AND ANTITHROMBOTICS, CALCIUM ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES | MERCK PATENT GMBH (DE) | 2002-06-27 | — | — | WO | disclosed |
| WO-2002041896-A2 | USE OF THIENOPYRIMIDINES | MERCK PATENT GMBH (DE) | 2002-05-30 | — | — | WO | disclosed |
| EP-1036078-A1 | THIENOPYRIMIDINES | MERCK PATENT GmbH (DE) | 2000-09-20 | — | — | EP | disclosed |
| WO-1999028325-A1 | THIENOPYRIMIDINES | MERCK PATENT GMBH (DE) | 1999-06-10 | — | — | WO | disclosed |